Quanticate is pleased to announce its strategic partnership with PhaseV, a pioneer in software and machine learning (ML) for adaptive clinical trial optimization on a new technology-based service.
Quanticate is pleased to announce its strategic partnership with KPS Life, a US-based provider of Functional Service Provision solutions focused on clinical operations and clinical monitoring oversight.
Quanticate is pleased to announce that we have been selected as a finalist for the Excellence in Use of Real-World Evidence category in the Citeline Awards 2023.
Quanticate, a global data-focused clinical research organization (CRO), has announced plans for further expansion and new jobs in 2023 as it thrives post-pandemic.
28 February is Rare Disease Day, and we proudly support this globally-coordinated movement working towards equity in social opportunity, healthcare, and access to diagnosis and therapies for people living with a rare disease.